65 related articles for article (PubMed ID: 11312369)
21. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
22. The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes.
Buseyne F; Rivière Y
Int Immunol; 2001 Jul; 13(7):941-50. PubMed ID: 11431424
[TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
Boggiano C; Moya R; Pinilla C; Bihl F; Brander C; Sidney J; Sette A; Blondelle SE
Eur J Immunol; 2005 May; 35(5):1428-37. PubMed ID: 15789356
[TBL] [Abstract][Full Text] [Related]
24. Understanding the genetic diversity of HIV-1.
McCutchan FE
AIDS; 2000; 14 Suppl 3():S31-44. PubMed ID: 11086847
[No Abstract] [Full Text] [Related]
25. HIV-1 nomenclature proposal.
Robertson DL; Anderson JP; Bradac JA; Carr JK; Foley B; Funkhouser RK; Gao F; Hahn BH; Kalish ML; Kuiken C; Learn GH; Leitner T; McCutchan F; Osmanov S; Peeters M; Pieniazek D; Salminen M; Sharp PM; Wolinsky S; Korber B
Science; 2000 Apr; 288(5463):55-6. PubMed ID: 10766634
[No Abstract] [Full Text] [Related]
26. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism.
Sette A; Sidney J
Immunogenetics; 1999 Nov; 50(3-4):201-12. PubMed ID: 10602880
[TBL] [Abstract][Full Text] [Related]
27. AIDS and HIV vaccines.
Klein M
Vaccine; 1999 Oct; 17 Suppl 2():S65-70. PubMed ID: 10506410
[TBL] [Abstract][Full Text] [Related]
28. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.
Dorrell L; Dong T; Ogg GS; Lister S; McAdam S; Rostron T; Conlon C; McMichael AJ; Rowland-Jones SL
J Virol; 1999 Feb; 73(2):1708-14. PubMed ID: 9882385
[TBL] [Abstract][Full Text] [Related]
29. Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.
Lynch JA; deSouza M; Robb MD; Markowitz L; Nitayaphan S; Sapan CV; Mann DL; Birx DL; Cox JH
J Infect Dis; 1998 Oct; 178(4):1040-6. PubMed ID: 9806032
[TBL] [Abstract][Full Text] [Related]
30. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
31. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires.
Bousso P; Casrouge A; Altman JD; Haury M; Kanellopoulos J; Abastado JP; Kourilsky P
Immunity; 1998 Aug; 9(2):169-78. PubMed ID: 9729037
[TBL] [Abstract][Full Text] [Related]
32. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
33. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection.
Busch DH; Pilip I; Pamer EG
J Exp Med; 1998 Jul; 188(1):61-70. PubMed ID: 9653084
[TBL] [Abstract][Full Text] [Related]
34. Progress in the development of an HIV-1 vaccine.
Letvin NL
Science; 1998 Jun; 280(5371):1875-80. PubMed ID: 9632379
[TBL] [Abstract][Full Text] [Related]
35. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
[TBL] [Abstract][Full Text] [Related]
36. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
[TBL] [Abstract][Full Text] [Related]
37. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.
Betts MR; Krowka J; Santamaria C; Balsamo K; Gao F; Mulundu G; Luo C; N'Gandu N; Sheppard H; Hahn BH; Allen S; Frelinger JA
J Virol; 1997 Nov; 71(11):8908-11. PubMed ID: 9343257
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
[TBL] [Abstract][Full Text] [Related]
39. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development.
Threlkeld SC; Wentworth PA; Kalams SA; Wilkes BM; Ruhl DJ; Keogh E; Sidney J; Southwood S; Walker BD; Sette A
J Immunol; 1997 Aug; 159(4):1648-57. PubMed ID: 9257824
[TBL] [Abstract][Full Text] [Related]
40. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.
Doolan DL; Hoffman SL; Southwood S; Wentworth PA; Sidney J; Chesnut RW; Keogh E; Appella E; Nutman TB; Lal AA; Gordon DM; Oloo A; Sette A
Immunity; 1997 Jul; 7(1):97-112. PubMed ID: 9252123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
